Reduced PTPRS expression promotes epithelial-mesenchymal transition of Schwann cells in NF1-related plexiform neurofibromas
Cancer Letters · 2024
DOI: 10.1016/j.canlet.2024.217151 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Letters, 2024. Verfasst von Yuehua Li und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Plastic and Reconstructive Surgery, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 20001…. Hauptthemen laut MEDLINE: Cell Movement, Epithelial-Mesenchymal Transition, ErbB Receptors, Neurofibroma, Plexiform. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Plexiform neurofibromas (PNFs) are a prevalent and severe phenotype associated with NF1, characterized by a high teratogenic rate and potential for malignant transformation. The growth and recurrence of PNFs are attributed to aberrant proliferation and migration of Nf1-deficient Schwann cells. Protein tyrosine phosphatase receptor S (PTPRS) is believed to modulate cell migration and invasion by inhibiting the EMT process in NF1-derived malignant peripheral nerve sheath tumors. Nevertheless, the specific role of PTPRS in NF1-derived PNFs remains to be elucidated. The study utilized the GEO database and tissue microarray to illustrate a decrease in PTPRS expression in PNF tissues, linked to tumor recurrence. Furthermore, the down- and over-expression of PTPRS in Nf1-deficient Schwann cell lines resulted in the changes of cell migration and EMT processes. Additionally, RTK assay and WB showed that PTPRS knockdown can promote EGFR expression and phosphorylation. The restoration of EMT processes disrupted by alterations in PTPRS levels in Schwann cells can be achieved through EGFR knockdown and EGFR inhibitor. Moreover, high EGFR expression has been significantly correlated with poor prognosis. These findings underscore the potential role of PTPRS as a tumor suppressor in the recurrence of PNF via the regulation of EGFR-mediated EMT processes, suggesting potential targets for future clinical interventions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Plastic and Reconstructive Surgery, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200011, China; Neurofibromatosis Type 1 Center and Laboratory for Neurofibr…
Zitieren
APA
Li, Y., Liu, J., Huang, J., Wei, C., Ge, L., Chung, M., Zhu, B., Guo, Z., Zheng, T., Li, H., Gu, Y., Wang, W., Li, Q., & Wang, Z. (2024). Reduced PTPRS expression promotes epithelial-mesenchymal transition of Schwann cells in NF1-related plexiform neurofibromas. Cancer Letters. https://doi.org/10.1016/j.canlet.2024.217151
Vancouver
Li Y, Liu J, Huang J, Wei C, Ge L, Chung M, et al. Reduced PTPRS expression promotes epithelial-mesenchymal transition of Schwann cells in NF1-related plexiform neurofibromas. Cancer Letters. 2024. doi:10.1016/j.canlet.2024.217151
BibTeX
@article{Li2024,
author = {Li, Yuehua and Liu, Jun and Huang, Jingxuan and Wei, Chengjiang and Ge, Lingling and Chung, Manhon and Zhu, Beiyao and Guo, Zizhen and Zheng, Tingting and Li, Haibo and Gu, Yihui and Wang, Wei and Li, Qingfeng and Wang, Zhichao},
title = {Reduced PTPRS expression promotes epithelial-mesenchymal transition of Schwann cells in NF1-related plexiform neurofibromas},
journal = {Cancer Letters},
year = {2024},
doi = {10.1016/j.canlet.2024.217151}
}
EUVIMED